Table 1.
Baseline Characteristics of All Subjects According to HT by Gender
| Characteristic | Overall (n=3697) |
Males (n=1745) | p value | Females (n=1952) | p value | ||
|---|---|---|---|---|---|---|---|
| HT (n=358) | Non-HT (n=1387) | HT (n=512) | Non-HT (n=1440) | ||||
| Age (years) | 45.74±11.42 | 48.93±10.85 | 48.06±11.22 | 0.190 | 45.03±11.43 | 42.95±11.06 | <0.001 |
| Smoking (n, %) | 1004 (27.2%) | 169 (47.2%) | 639 (46.1%) | 0.441 | 56 (10.9%) | 140 (9.7%) | 0.721 |
| Drinking (n, %) | 646 (17.5%) | 134 (37.4%) | 484 (34.9%) | 0.386 | 11 (2.1%) | 17 (1.2%) | 0.130 |
| WC (cm) | 80.54±10.15 | 90.24±7.86 | 86.90±7.58 | <0.001 | 76.13±8.64 | 73.57±7.03 | <0.001 |
| HC (cm) | 93.55±5.81 | 97.36±5.78 | 97.39±5.30 | <0.001 | 92.37±5.99 | 91.23±5.07 | <0.001 |
| WHR | 0.86±0.08 | 0.92±0.05 | 0.91±0.05 | <0.001 | 0.82±0.07 | 0.81±0.06 | <0.001 |
| BMI (kg/m2) | 23.93±3.35 | 26.43±3.08 | 25.15±2.90 | <0.001 | 23.27±3.57 | 22.37±2.87 | <0.001 |
| SBP (mmHg) | 119.14±16.24 | 129.38±15.54 | 124.83±13.61 | <0.001 | 115.52±16.20 | 112.41±15.44 | <0.001 |
| DBP (mmHg) | 72.56±10.50 | 77.99±11.19 | 75.69±9.78 | <0.001 | 70.43±9.76 | 68.96±9.71 | 0.003 |
| Hypertension (n, %) | 364 (9.8%) | 77 (21.5%) | 171 (12.3%) | <0.001 | 41 (8.0%) | 75 (5.2%) | 0.029 |
| FBG (mmol/L) | 5.23±1.02 | 5.54±1.46 | 5.46±1.20 | 0.286 | 5.04±0.62 | 5.01±0.70 | 0.391 |
| DM (n, %) | 169 (4.6%) | 29 (8.1%) | 100 (7.2%) | 0.571 | 12 (2.3%) | 28 (1.9%) | 0.588 |
| TC (mmol/L) | 4.79 [4.23, 5.40] | 4.89 [4.28, 5.46] | 4.85 [4.25, 5.43] | 0.695 | 4.68 [4.11, 5.32] | 4.75 [4.22, 5.37] | 0.108 |
| TG (mmol/L) | 1.12 [0.76, 1.74] | 1.76 [1.19, 2.44] | 1.48 [1.02, 2.15] | <0.001 | 0.96 [0.66, 1.47] | 0.85 [0.62, 1.18] | <0.001 |
| LDL-C (mmol/L) | 2.84 [2.42, 3.30] | 2.99 [2.52, 3.39] | 2.95 [2.53, 3.36] | 0.760 | 2.75 [2.36, 3.20] | 2.75 [2.36, 3.21] | 0.964 |
| HDL-C (mmol/L) | 1.37 [1.16, 1.60] | 1.19 [1.05, 1.37] | 1.22 [1.07, 1.40] | 0.054 | 1.45 [1.23, 1.68] | 1.53 [1.34, 1.76] | <0.001 |
| WBC (×109/L) | 5.87±1.39 | 6.27±1.38 | 6.23±1.43 | 0.666 | 5.54±1.30 | 5.55±1.28 | 0.921 |
| NE (×109/L) | 3.24±1.02 | 3.40±0.98 | 3.43±1.04 | 0.626 | 3.08±1.01 | 3.08±0.97 | 0.878 |
| FT3 (pmol/L) | 4.80 [4.45, 5.17] | 5.01 [4.69, 5.35] | 4.99 [4.65, 5.35] | 0.518 | 4.63 [4.32, 4.96] | 4.62 [4.31, 4.99] | 0.977 |
| FT4 (pmol/L) | 11.06 [10.12, 12.11] | 10.91 [9.85, 11.90] | 11.33 [10.36, 12.32] | <0.001 | 10.89 [9.92, 11.86] | 10.97 [10.03, 11.98] | 0.105 |
| TSH (mU/L) | 1.99 [1.41, 2.81] | 2.19 [1.60, 3.02] | 1.83[1.32, 2.56] | <0.001 | 2.33 [1.64, 3.38] | 1.99 [1.39, 2.77] | <0.001 |
Notes: Normally distributed continuous variables are presented as the mean ± standard deviation. Non-normally distributed continuous variables are presented as the mean [interquartile range]. Categorical variables are presented as the number (percentage).
Abbreviations: HT, Hashimoto’s thyroiditis; WC, waist circumference; HC, hip circumference; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; TG, triglycerides; TC, total cholesterol; LDL-C, low-density lipoprotein cholesterol; HDL-c, high-density lipoprotein cholesterol; FBG, fasting blood glucose; DM, diabetes mellitus; WBC, white blood cells; NE, neutrophils; TSH, thyroid-stimulating hormone; FT3, free triiodothyronine; FT4, thyroxine.